Related Experiment Videos
[Rare breast tumors]
F Haberthür1, J Torhorst, G E Feichter
1Universitäts-Frauenklinik, Basel.
Therapeutische Umschau. Revue Therapeutique
|May 1, 1993
Summary
This study highlights that breast sarcomas are rare mammary malignancies. Wide local excision or simple mastectomy are recommended treatments, with adjuvant therapies showing no proven value.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Breast sarcomas and cystosarcoma phylloides are rare mammary malignancies, accounting for 0.2–1% and 0.3–0.9% of breast tumors, respectively.
- These tumors can present with distinct clinical phases and are prone to recurrence after removal.
Observation:
- The study details four cases of breast sarcoma, including osteosarcoma, fibrosarcoma, and malignant fibrous sarcoma.
- Treatment approaches varied, with mastectomy and axillary lymph node dissection in three cases, and simple mastectomy in one.
Findings:
- One patient experienced local recurrence and mortality.
- The remaining three patients, observed for 18 months to 17 years, showed no metastases or local recurrence after initial treatment.
- Wide local excision or simple mastectomy are identified as effective first-line treatments.
Implications:
- The findings suggest that wide local excision or simple mastectomy are the primary recommended treatments for breast sarcoma.
- Adjuvant therapies such as axillary lymph node dissection, radiotherapy, or chemotherapy do not appear to offer proven benefits in managing breast sarcoma.